Pacific Biosciences
PACB
PACB
148 hedge funds and large institutions have $607M invested in Pacific Biosciences in 2019 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4.82% less ownership
Funds ownership: 81.67% → 76.85% (-4.8%)
20% less capital invested
Capital invested by funds: $756M → $607M (-$150M)
54% less call options, than puts
Call options by funds: $712K | Put options by funds: $1.56M
Holders
148
Holding in Top 10
3
Calls
$712K
Puts
$1.56M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$7.49M | |
| 3 | +$6.39M | |
| 4 |
VI
Versor Investments
New York
|
+$5.11M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.06M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$16.3M | |
| 3 | -$10.7M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$6.94M |
| 5 |
EMPI
Elo Mutual Pension Insurance
Espoo,
Finland
|
-$5.1M |